Proto Labs Inc. is expanding its capabilities past its historical prototyping specialty over the next five years to conform to customers' more "traditional" processing and full-service production ...
West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair reiterated its Outperform rating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback